SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients (CVIM 1 study)

Immunogenicity following inactivated SARS-CoV-2 vaccination among solid organ transplant recipients has not been assessed. Seventy-five patients (37 kidney transplant [KT] recipients and 38 healthy controls) received two doses, at 4-week intervals, of an inactivated whole-virus SARS-CoV-2 vaccine. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruminhent, Jackrapong, Setthaudom, Chavachol, Chaumdee, Pongsathon, Boongird, Sarinya, Kiertiburanakul, Sasisopin, Malathum, Kumthorn, Nongnuch, Arkom, Phuphuakrat, Angsana, Jirasiritham, Sopon, Janphram, Chitimaporn, Thotsiri, Sansanee, Upama, Supparat, Assanatham, Montira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652697/
https://www.ncbi.nlm.nih.gov/pubmed/34657386
http://dx.doi.org/10.1111/ajt.16867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652697/
https://www.ncbi.nlm.nih.gov/pubmed/34657386
http://dx.doi.org/10.1111/ajt.16867

Ejemplares similares